Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU Patients

NCT05146154 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Investigator is no longer at University of Illinois

Conditions

Obesity
Critical Illness

Interventions

DRUG: Imipenem/Cilastatin/Relebactam 1.25g

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]